CPT code 85210: Factor II assay, prothrombin measurement2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Measures clotting factor II, or prothrombin, when evaluating suspected factor deficiency or abnormal coagulation results in a bleeding evaluation.
Medicare pays $12.98 for 85210 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$12.98
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 7 sections
What 85210 covers
This laboratory assay measures clotting factor II, also known as prothrombin, in a patient specimen. Clinicians may order it when evaluating suspected inherited or acquired factor II deficiency, unexplained bleeding, or abnormal coagulation results. Coagulation laboratories generally perform factor assays on plasma collected for coagulation testing. The result is assessed alongside the patient’s symptoms and other laboratory findings.
Report this code for the factor II measurement, not for a general prothrombin time or an assay of another clotting factor. Medicare pays it through the CLFS. The 2026 national CLFS amount is $12.98, unchanged from 2020 through 2026. The same amount applies across localities, without geographic or office-versus-facility adjustment. This code is paid only from the CLFS, rather than the physician fee schedule.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 85210
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 85210. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 85210 with status X (excluded by statute), so the test itself is paid only from the CLFS.
85210 on the lab fee schedule since 2020
85210 · CLFS 2026 Q4 (current)
$12.98
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
85210 compared with similar tests
- 85220Factor V assayActivity measurement$17.65
- Choose 85220 when the laboratory measures factor V. Code 85210 is for prothrombin, or factor II.
- 85230Factor VII assayProconvertin activity$17.90
- Choose 85230 for a factor VII measurement; use 85210 when factor II is the analyte.
- 85610Prothrombin timeRoutine coagulation test$4.29
- A prothrombin time evaluates clotting time, while 85210 measures factor II specifically. An abnormal prothrombin time alone does not make the factor II assay interchangeable with that test.
- 85730Partial thromboplastin timePTT, plasma or whole blood$6.01
- Code 85210 measures factor II. Code 85730 is for a partial thromboplastin time, a broader coagulation test rather than a factor-specific assay.
85210 billing questions
When should this code be used instead of a prothrombin time?
Use this code when the laboratory measures factor II itself. A prothrombin time evaluates clotting time and does not identify factor II on its own.
How is this different from the factor V assay?
This assay measures prothrombin, or factor II. Code 85220 is for a factor V measurement.
What should the laboratory documentation identify?
Document the factor II assay performed and the patient specimen tested. The record should support that the measured analyte was prothrombin rather than another coagulation factor.
How does Medicare pay for this assay?
Medicare pays it under the CLFS at one national amount, with no locality or office-versus-facility adjustment. It is paid only from the CLFS.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 85210 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist